期刊文献+

系统性硬化症合并肺间质病变患者血清中KL-6及SP-D水平与肺功能参数的关系 被引量:4

Association between serum KL-6 and SP-D levels and lung function parameters in patients with systemic sclerosis combined with interstitial lung disease
下载PDF
导出
摘要 目的通过检测系统性硬化症(SSc)合并间质性肺病(ILD)患者血清中肺表面活性蛋白D(SP-D)和Ⅱ型肺泡细胞表面抗原(KL-6),分析其与患者临床症状、免疫学指标及肺功能的相关性,探索诊断ILD的新血清学指标。方法收集安徽省立医院风湿免疫科2013年1~10月住院及门诊确诊为SSc患者35例,其中SSc-ILD组20例,SSc-非ILD组15例,正常对照组选择年龄、性别相匹配的19例我院门诊健康体检者。采用ELISA法检测所有研究对象血清中SP-D和KL-6的水平。比较SSc组、SSc-ILD组、SSc-非ILD组、正常对照组血清样本中SP-D和KL-6的水平,分析上述血清学指标与肺功能指标的相关性。结果 1血清中KL-6、SP-D水平SSc-ILD组患者高于正常对照组,差异有统计学意义(P<0.05),SSc-ILD组显著高于SSc-非ILD组(P<0.05),而SSc-非ILD组与正常对照组比较,差异无统计学意义(P>0.05);2 SSc患者血清中KL-6、SPD与肺功能指标用力肺活量(FVC)、一氧化碳弥散量(DLCO)、肺活量(VC)呈负相关(P<0.05),其中KL-6与血沉(ESR)、C反应蛋白(CRP)、Ig G、Ig A、Ig M无相关性,SP-D与Ig G、Ig M呈负相关(P<0.05),与ESR、CRP、Ig A无相关性。结论 SSc合并ILD患者血清中KL-6、SP-D水平显著升高,SSc患者血清中KL-6、SP-D水平与肺功能指标呈负相关;血清KL-6、SP-D可能作为诊断与评估SSc-ILD病情严重程度的血清学指标。 Objective To examine the serum levels of pulmonary surfactant protein-D( SP-D) and Krebs Von den Lungen-6( KL-6)in the patients with systemic sclerosis( SSc) combined with interstitial lung disease( ILD),and to analyze their correlations with the clinical signs,immunological indexes and lung function in search for novel serum diagnostic biomarkers of ILD. Methods From Jan 2013 to Oct2013,thirty-five cases of SSc patients diagnosed in our hospital were collected. The serum KL-6 and SP-D levels of all research objects,including 15 SSc-non ILD patients,20 SSc-ILD patients and 19 age- and sex-matched healthy controls,were examined by ELISA. The serum levels of KL-6 and SP-D among the SSc group,the SSc-ILD group,the SSc-non ILD group and the control group were compared,and the correlations between above serological results and pulmonary function indexes were analyzed. Results The serum KL-6 and SP-D levels in the SSc-ILD group were significantly higher than those in the SSc-non ILD and control groups( P < 0. 05). However,no significant difference was found between those SSc-non ILD patients and healthy controls( P > 0. 05). In the SSc patients,their pulmonary function results of diffusing capacity of the lung for carbon monoxide( DLCO),forced vital capacity( FVC) and vital capacity( VC) were negatively correlated with the serum KL-6 and SP-D levels. And the SP-D levels were negatively correlated with the Ig G and Ig M levels,irrelevant to the erythrocyte sedimentation rate( ESR),C-reactive protein( CRP) and Ig A levels. No correlation was found between the KL-6 levels and the ESR,CRP,Ig G,Ig A and Ig M levels. Conclusion The serum KL-6 and SP-D levels of SSc patients combined with ILD increase significantly,and are negatively correlated with the lung function indexes. The serological indexes of serum KL-6 and SP-D levels may be helpful to diagnose and assess the disease severity of those SSc-ILD patients.
出处 《安徽医学》 2016年第8期940-943,944,共5页 Anhui Medical Journal
基金 安徽省2012年度科技计划项目基金(项目编号:12070403052)
关键词 系统性硬化症 肺间质病变 肺功能 肺表面活性蛋白-D Ⅱ型肺泡细胞表面抗原 Systemic sclerosis Interstitial lung disease Lung function Surfactant protein-D Krebs Von den Lungen-6
  • 相关文献

参考文献7

  • 1Harrison N K,Myers A R,Corrin B,Soosay G,Dewar A,Black C M,Du Bois R M,Turner-Warwick M.Structural features of interstitial lung disease in systemic sclerosis. The American review of respiratory disease . 1991
  • 2Yamane K,Ihn H,Kubo M,Yazawa N,Kikuchi K,Soma Y,Tamaki K.Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. The Journal of rheumatology . 2000
  • 3Akira Seko,Takashi Ohkura,Hiroko Ideo,Katsuko Yamashita.Novel O-linked glycans containing 6-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: Possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody. Glycobiology . 2012
  • 4Hara Ryusuke,Itami Jun,Komiyama Takafumi,Katoh Daiki,Kondo Tatsuya.Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors. Chest . 2004
  • 5Yanaba Koichi,Hasegawa Minoru,Takehara Kazuhiko,Sato Shinichi.Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis. The Journal of rheumatology . 2004
  • 6Matalon Sadis,Shrestha Kedar,Kirk Marion,Waldheuser Stephanie,McDonald Barbara,Smith Kelly,Gao Zhiqian,Belaaouaj Abderrazzak,Crouch Erika C.Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology . 2009
  • 7Austin J H,Müller N L,Friedman P J,Hansell D M,Naidich D P,Remy-Jardin M,Webb W R,Zerhouni E A.Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology . 1996

同被引文献28

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部